Conflict of interest: The MADIT-II study was supported by a research grant from Guidant Corp., St. Paul, Minnesota, to the University of Rochester School of Medicine and Dentistry.
Effectiveness of Cardiac Resynchronization Therapy in Diabetic Patients with Ischemic and Nonischemic Cardiomyopathy
Article first published online: 26 JAN 2012
© 2012, Wiley Periodicals, Inc.
Annals of Noninvasive Electrocardiology
Volume 17, Issue 1, pages 14–21, January 2012
How to Cite
George, J., Barsheshet, A., Moss, A. J., Martin, D., Ouellet, G., McNitt, S. and Goldenberg, I. (2012), Effectiveness of Cardiac Resynchronization Therapy in Diabetic Patients with Ischemic and Nonischemic Cardiomyopathy. Annals of Noninvasive Electrocardiology, 17: 14–21. doi: 10.1111/j.1542-474X.2011.00476.x
- Issue published online: 26 JAN 2012
- Article first published online: 26 JAN 2012
This article has been cited by:
- 1Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes, Journal of Diabetes Research, 2016, 2016, 1, , , , , ,
- 2Effect on Cardiac Function of Cardiac Resynchronization Therapy in Patients With Right Bundle Branch Block (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT] Trial), The American Journal of Cardiology, 2013, 112, 4, 525, , , , , , ,